Major Shareholders

Summary of Issued Securities 

Ordinary Shares

 
Issued shares at 31 December 2017 319,720,344
Employee options over ordinary shares at 31 December 2017 13,777,250

Major Shareholders 
The top 20 shareholders in Pharmaxis Ltd on 31 December 2017 are:

Name

Number Of Shares

'000

% Total 
1. Citicorp Nominees Pty Limited 88,584 28%
2. National Nominees Limited 38,876 12%
3. HSBC Custody Nominees (Australia) Limited  26,836  8%
4. JP Morgan Nominees Australia Limited 16,132 5%
5. Moggs Creek Pty Ltd (Moggs Creek Super A/C) 3,005 1%
6. George Engineering Pty Ltd (PG Super Fund) 2,500 1%
7. Mr Yingkai Li 2,450 1%
8. David Newnham Super Pty Ltd 2,289 1%
9. Healthcare Management Consulting (Australia) Pty Ltd 2,220 1%
10. Pakasoluto Pty Limited (Barkl Family Super Fund A/C) 2,087 1%
11. Simgon Pty Ltd (RK Super A/C) 1,750 1%
12. Alpha Matilda Trading Pty Ltd 1,615 1%
13. Lawn Views Pty Ltd 1,253 0%
14. Mr Marco Andrea Negro  1,200 0% 
15. HSBC Custody Nominees (Australia) Limited - GSCO ECA 1,178 0%
16. Ms Bei Xu + Mr Dongning Wu 1,160 0%
17. Ginga Pty Ltd (TG Klinger S/F a/c) 1,159 0%
18. Mr Brian Tully & Mrs Margaret Tully 1,146 0%
19. Killcare Holdings Pty Ltd 1,104 0%
20. Capital Regional et Cooperatif Desjardins 1,054 0%

Note: the above tables are updated after each quarter end

Substantial Shareholders 
Pharmaxis has received the following substantial shareholder notices: 

Name Percent Date 
BVF Partners LP 19.97% 30 August 2017
Australian Ethical Australian Share Fund 10.16% 3 April 2017
Allan Gray Australia 7.00% 29 August 2017
Montoya Investments Limited 6.20% 12 April 2013